APA (7th ed.) Citation

André Schreiber, Benjamin Ambrosy, Oliver Planz, Sebastian Schloer, Ursula Rescher, & Stephan Ludwig. (2022). The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. MDPI AG.

Chicago Style (17th ed.) Citation

André Schreiber, Benjamin Ambrosy, Oliver Planz, Sebastian Schloer, Ursula Rescher, and Stephan Ludwig. The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. MDPI AG, 2022.

MLA (9th ed.) Citation

André Schreiber, et al. The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. MDPI AG, 2022.